161 related articles for article (PubMed ID: 36473425)
41. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
[TBL] [Abstract][Full Text] [Related]
42. Body composition in preterm infants who are fed long-chain polyunsaturated fatty acids: a prospective, randomized, controlled trial.
Groh-Wargo S; Jacobs J; Auestad N; O'Connor DL; Moore JJ; Lerner E
Pediatr Res; 2005 May; 57(5 Pt 1):712-8. PubMed ID: 15718356
[TBL] [Abstract][Full Text] [Related]
43. Enteral zinc supplementation for prevention of morbidity and mortality in preterm neonates.
Staub E; Evers K; Askie LM
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012797. PubMed ID: 33710626
[TBL] [Abstract][Full Text] [Related]
44. Docosahexaenoic and Arachidonic Acid Supplementation of Toddlers Born Preterm Does Not Affect Short-Term Growth or Adiposity.
Ingol TT; Li R; Boone KM; Rausch J; Klebanoff MA; Turner AN; Yeates KO; Nelin MA; Sheppard KW; Keim SA
J Nutr; 2019 Dec; 149(12):2182-2190. PubMed ID: 31187863
[TBL] [Abstract][Full Text] [Related]
45. High-Dose Docosahexaenoic Acid in Newborns Born at Less Than 29 Weeks' Gestation and Behavior at Age 5 Years: Follow-Up of a Randomized Clinical Trial.
Gould JF; Roberts RM; Anderson PJ; Makrides M; Sullivan TR; Gibson RA; McPhee AJ; Doyle LW; Bednarz JM; Best KP; Opie G; Travadi J; Cheong JLY; Davis PG; Sharp M; Simmer K; Tan K; Morris S; Lui K; Bolisetty S; Liley H; Stack J; Collins CT
JAMA Pediatr; 2024 Jan; 178(1):45-54. PubMed ID: 37983037
[TBL] [Abstract][Full Text] [Related]
46. Evidence on docosahexaenoic acid and arachidonic acid supplementation for preterm infants.
Lapillonne A; Lembo C; Moltu SJ
Curr Opin Clin Nutr Metab Care; 2024 May; 27(3):283-289. PubMed ID: 38547330
[TBL] [Abstract][Full Text] [Related]
47. Dose-dependent effect of human milk on Bronchopulmonary dysplasia in very low birth weight infants.
Xu Y; Yu Z; Li Q; Zhou J; Yin X; Ma Y; Yin Y; Jiang S; Zhu R; Wu Y; Han L; Gao Y; Xue M; Qiao Y; Zhu L; Tu W; Wu M; Wan J; Wang W; Deng X; Li S; Wang S; Chen X; Zhou Q; Wang J; Cheng R; Wang J; Han S
BMC Pediatr; 2020 Nov; 20(1):522. PubMed ID: 33190629
[TBL] [Abstract][Full Text] [Related]
48. Extremely preterm infants receiving standard care receive very low levels of arachidonic and docosahexaenoic acids.
De Rooy L; Hamdallah H; Dyall SC
Clin Nutr; 2017 Dec; 36(6):1593-1600. PubMed ID: 27756480
[TBL] [Abstract][Full Text] [Related]
49. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates.
Atwell K; Collins CT; Sullivan TR; Ryan P; Gibson RA; Makrides M; McPhee AJ
J Paediatr Child Health; 2013 Jan; 49(1):E17-22. PubMed ID: 23279074
[TBL] [Abstract][Full Text] [Related]
50. Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age.
Auestad N; Scott DT; Janowsky JS; Jacobsen C; Carroll RE; Montalto MB; Halter R; Qiu W; Jacobs JR; Connor WE; Connor SL; Taylor JA; Neuringer M; Fitzgerald KM; Hall RT
Pediatrics; 2003 Sep; 112(3 Pt 1):e177-83. PubMed ID: 12949309
[TBL] [Abstract][Full Text] [Related]
51. Early docosahexaenoic and arachidonic acid supplementation in extremely-low-birth-weight infants.
Robinson DT; Caplan M; Carlson SE; Yoder R; Murthy K; Frost B
Pediatr Res; 2016 Oct; 80(4):505-10. PubMed ID: 27356083
[TBL] [Abstract][Full Text] [Related]
52. Assessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocol.
Carlson SE; Gajewski BJ; Valentine CJ; Rogers LK; Weiner CP; DeFranco EA; Buhimschi CS
BMC Pregnancy Childbirth; 2017 Feb; 17(1):62. PubMed ID: 28193189
[TBL] [Abstract][Full Text] [Related]
53. Effect of Maternal Docosahexaenoic Acid Supplementation on Very Preterm Infant Growth: Secondary Outcome of a Randomized Clinical Trial.
Angoa G; Pronovost E; Ndiaye ABKT; Lavoie PM; Lemyre B; Mohamed I; Simonyan D; Qureshi M; Afifi J; Yusuf K; Sériès T; Guillot M; Piedboeuf B; Fraser WD; Nuyt AM; Mâsse B; Lacaze-Masmonteil T; Marc I
Neonatology; 2022; 119(3):377-385. PubMed ID: 35413719
[TBL] [Abstract][Full Text] [Related]
54. Docosahexaenoic acid-rich algae oil supplementation on breast milk fatty acid profile of mothers who delivered prematurely: a randomized clinical trial.
Fougère H; Bilodeau JF; Lavoie PM; Mohamed I; Rudkowska I; Pronovost E; Simonyan D; Berthiaume L; Guillot M; Piedboeuf B; Julien P; Marc I
Sci Rep; 2021 Nov; 11(1):21492. PubMed ID: 34728723
[TBL] [Abstract][Full Text] [Related]
55. Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled Trial.
Best KP; Sullivan TR; Gunaratne AW; Gould JF; Gibson RA; Collins CT; Makrides M; Green TJ
Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678206
[TBL] [Abstract][Full Text] [Related]
56. Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: a review of randomized controlled trials.
Hoffman DR; Boettcher JA; Diersen-Schade DA
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):151-8. PubMed ID: 19505812
[TBL] [Abstract][Full Text] [Related]
57. Lipid emulsions for parenterally fed preterm infants.
Kapoor V; Malviya MN; Soll R
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD013163. PubMed ID: 31158919
[TBL] [Abstract][Full Text] [Related]
58. Enteral vitamin A for reducing severity of bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled trial.
Rakshasbhuvankar A; Patole S; Simmer K; Pillow JJ
BMC Pediatr; 2017 Dec; 17(1):204. PubMed ID: 29246130
[TBL] [Abstract][Full Text] [Related]
59. Early inhaled nitric oxide in preterm infants <34 weeks with evolving bronchopulmonary dysplasia.
Jiang Q; Gao X; Liu C; Chen D; Lin X; Xia S; Zhuang D; Yang C; Zhu W; Liu L; Chen C; Sun B
J Perinatol; 2016 Oct; 36(10):883-9. PubMed ID: 27442155
[TBL] [Abstract][Full Text] [Related]
60. Assessing whether early attention of very preterm infants can be improved by an omega-3 long-chain polyunsaturated fatty acid intervention: a follow-up of a randomised controlled trial.
Gould JF; Colombo J; Collins CT; Makrides M; Hewawasam E; Smithers LG
BMJ Open; 2018 May; 8(5):e020043. PubMed ID: 29804059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
